Author/Editor		Krajnc, Olga
Title		Racionalno zdravljenje s krvnimi pripravki v pediatriji
Translated title		Rational therapy by blood components in pediatry
Type		članek
Source		In: Urlep-Šalinović V, editor. Varnost in kakovost v transfuzijski medicini: včeraj, danes, jutri. Strokovno srečanje ob 60. obletnici transfuzijske dejavnosti v Univerzitetnem kliničnem centru Maribor; 2010 maj 7-8; Maribor. Maribor: Univerzitetni klinični center,
Publication year		2010
Volume		str. 201-10
Language		slo
Abstract		The treatment by blood components in pediatric practice is often an irreplaceable method of care, especially in the intensive care units, where the patients with dangerous infections, coagulation disorders, after chemotherapy and X-ray therapy, of organs, bone marrow, progenitor cells transplantation, are treated. When the patients are treated by blood components the benefits and risks have to be considered. In pediatric practice, fresh frozen plasma, red cell concentrates, platelets concentrates and X-ray irradiated blood components are commonly used, and very rarely granulocyte concentrates. In pediatry, autologous blood transfusion, hemodilution and intraoperative blood collection by cell saver are also used in elective surgery. In neonatology, the transitory anemia by premature neonates are successfully treated by recombinant erythropoietin.
Summary		Transfuzija krvnih pripravkov je v pediatriji večkrat nenadomestljivi način zdravljenja, posebno v enotah intenzivne nege in terapije, kjer se zdravijo bolniki z nevarnimi okužbami, motnjami strjevanja krvi, po kemoterapiji in po obsevanju, transplantaciji organov, kostnega mozga in matičnih celic. Pri zdravljenju s krvnimi pripravki moramo upoštevati koristnost in tveganost te oblike terapije. V pediatriji največ uporabljamo transfuzijo sveže zmrznjene plazme, koncentriranih eritrocitov, koncentriranih trombocitov in obsevanih krvnih pripravkov ter zelo, zelo redko koncentriranih granulocitov. Vedno bolj se v pediatriji ob načrtovanih operativnih posegih uveljavlja avtotransfuzija, hemodilucija in cell saver. V neonatologiji se je uspešno uveljavilo zdravljenje prehodne anemije nedonošenčkov z rekombinantnim eritropoetinom.
Descriptors		BLOOD COMPONENT TRANSFUSION QUALITY CONTROL SAFETY PEDIATRICS